ABIOMED, Inc. - Common Stock (NQ:ABMD)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Dec 21, 2022 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about ABIOMED, Inc. - Common Stock

< Previous 1 2 3 Next >

Risk Vs Reward Vs Folly: Navigating Investment Choices ↗

September 29, 2023

During the dot-com era, many individuals ridiculed Buffett for his refusal to invest in ventures that contradicted his principles. Years later, the majority of these so-called experts, if not all of...

Via Talk Markets

Is It Too Late to Buy Johnson & Johnson's Stock? ↗

April 28, 2023

This healthcare juggernaut's recent quarterly results prove just how strong its business is.

Via The Motley Fool

2 Best Buffett Stocks to Buy for the Long Haul ↗

December 27, 2022

Both of these stocks look like bargains right now.

Via The Motley Fool

Interest Rate Hikes Won't Stop These 2 Cash-Rich Growth Stocks ↗

December 21, 2022

Even if interest rates go up, you likely won't need to worry about these stocks.

Via The Motley Fool

The Best Stocks to Invest $20,000 in Right Now ↗

December 21, 2022

The investments you make now could power your portfolio returns for years to come.

Via The Motley Fool

Warren Buffett Loves These Stocks. Should You Buy Them Before 2023? ↗

December 16, 2022

There's a lot more ahead for these market giants.

Via The Motley Fool

If You Invested $100 In This Stock 10 Years Ago, You Would Have $2,800 Today ↗

December 08, 2022

Via Benzinga

Here's How Much You Would Have Made Owning Abiomed Stock In The Last 15 Years ↗

November 21, 2022

Via Benzinga

Will Investors Notice Exciting Sign On Abiomed's Chart? ↗

November 16, 2022

Via Benzinga

Pfizer, Novartis Are Among Overbought Healthcare Stocks: Are They Worth A Look? ↗

December 14, 2022

The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies. Here’s the latest list of major overbought players in this sector, with an RSI...

Via Benzinga

2 Top Dividend Kings to Buy for the Long Haul ↗

December 14, 2022

No matter how much changes, these two healthcare giants keep performing.

Via The Motley Fool

This Monster Dividend Stock Isn't Done Growing ↗

December 08, 2022

Is another deal on the way for Johnson & Johnson?

Via The Motley Fool

Horizon Topples After J&J Pulls Out Of Bidding War, Leaving Amgen, Sanofi ↗

December 05, 2022

There are now two companies in the ring for a Horizon takeover.

Via Investor's Business Daily

3 Healthcare Stocks to Buy and Hold for the Next 10 Years ↗

December 02, 2022

This space is ripe with opportunities for investors.

Via The Motley Fool

Beat the Dow Jones With This Unstoppable Dividend Stock ↗

November 05, 2022

Johnson & Johnson has outperformed the Dow so far this year.

Via The Motley Fool

Analyst Forecasts $101-117/Share Offer Price For Horizon Therapeutics' Buyout ↗

November 30, 2022

Via Benzinga

Bear Market Blues? 3 of the Best Stocks to Own in 2023 ↗

November 19, 2022

2023 could be a big year for each of these healthcare companies.

Via The Motley Fool

Peering Into Abiomed's Recent Short Interest ↗

November 17, 2022

Abiomed's (NASDAQ:ABMD) short percent of float has risen 6.62% since its last report. The company recently reported that it has 2.08 million shares sold short, which is 5.96% of all regular shares that...

Via Benzinga

2 Warren Buffett Passive Income Stocks You Can Buy to Boost Your Yield ↗

November 11, 2022

Buffett loves stocks that pay dividends. Is it any wonder Berkshire Hathaway is poised to collect more than $6 billion worth of them next year?

Via The Motley Fool

Better Buy: Johnson & Johnson vs. Abbott Laboratories ↗

November 10, 2022

These two healthcare giants are among the safest stocks investors can buy right now.

Via The Motley Fool

Johnson & Johnson Could Level Up With Its $16.8 Billion Purchase of Abiomed ↗

November 10, 2022

The company is planting seeds for future growth.

Via The Motley Fool

2 Healthcare Stocks You Can Buy and Hold for the Next Decade ↗

November 08, 2022

These robust businesses will be around well beyond the next 10 years.

Via The Motley Fool

3 No-Brainer Stocks to Buy in a Downturn ↗

November 08, 2022

These companies thrive when others falter.

Via The Motley Fool

Johnson & Johnson's Big Purchase, Amazon's New Moves, and More ↗

November 05, 2022

Plus, we run through some shortcuts that could help you with your financial planning.

Via The Motley Fool

Is Johnson & Johnson's Purchase of Abiomed Good for Investors? ↗

November 05, 2022

The $16.6 billion acquisition shakes up MedTech.

Via The Motley Fool

Stock Market Rally Tumbles On Hawkish Fed Chief Powell; Jobs, Earnings Also In Focus: Weekly Review ↗

November 04, 2022

A mixed jobs report and heavy earnings swung stocks.

Via Investor's Business Daily

Here's How Much $100 Invested In Abiomed 20 Years Ago Would Be Worth Today ↗

November 04, 2022

Abiomed (NASDAQ:ABMD) has outperformed the market over the past 20 years by 18.13% on an annualized basis producing an average annual return of 25.63%. Currently, Abiomed has a market capitalization of...

Via Benzinga

5 Analysts Have This to Say About Abiomed ↗

November 02, 2022

Over the past 3 months, 5 analysts have published their opinion on Abiomed (NASDAQ:ABMD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022 ↗

November 02, 2022

Upgrades

Via Benzinga

Is Johnson & Johnson an Underrated Growth Stock? ↗

November 02, 2022

Johnson & Johnson trades at a modest earnings multiple, and it may warrant a premium.

Via The Motley Fool

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.